174 related articles for article (PubMed ID: 29935962)
1. A patient with a GNAO1 mutation with decreased spontaneous movements, hypotonia, and dystonic features.
Okumura A; Maruyama K; Shibata M; Kurahashi H; Ishii A; Numoto S; Hirose S; Kawai T; Iso M; Kataoka S; Okuno Y; Muramatsu H; Kojima S
Brain Dev; 2018 Nov; 40(10):926-930. PubMed ID: 29935962
[TBL] [Abstract][Full Text] [Related]
2. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
[TBL] [Abstract][Full Text] [Related]
3. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey.
Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP
Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551
[TBL] [Abstract][Full Text] [Related]
4. [GNAO1: a new gene to consider on early-onset childhood dystonia].
Marecos C; Duarte S; Alonso I; Calado E; Moreira A
Rev Neurol; 2018 May; 66(9):321-322. PubMed ID: 29696620
[TBL] [Abstract][Full Text] [Related]
5. GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype.
Arya R; Spaeth C; Gilbert DL; Leach JL; Holland KD
Epileptic Disord; 2017 Mar; 19(1):67-75. PubMed ID: 28202424
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
[TBL] [Abstract][Full Text] [Related]
7. Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation.
Kulkarni N; Tang S; Bhardwaj R; Bernes S; Grebe TA
J Child Neurol; 2016 Feb; 31(2):211-4. PubMed ID: 26060304
[TBL] [Abstract][Full Text] [Related]
8. Highlighting the Dystonic Phenotype Related to GNAO1.
Wirth T; Garone G; Kurian MA; Piton A; Millan F; Telegrafi A; Drouot N; Rudolf G; Chelly J; Marks W; Burglen L; Demailly D; Coubes P; Castro-Jimenez M; Joriot S; Ghoumid J; Belin J; Faucheux JM; Blumkin L; Hull M; Parnes M; Ravelli C; Poulen G; Calmels N; Nemeth AH; Smith M; Barnicoat A; Ewenczyk C; Méneret A; Roze E; Keren B; Mignot C; Beroud C; Acosta F; Nowak C; Wilson WG; Steel D; Capuano A; Vidailhet M; Lin JP; Tranchant C; Cif L; Doummar D; Anheim M
Mov Disord; 2022 Jul; 37(7):1547-1554. PubMed ID: 35722775
[TBL] [Abstract][Full Text] [Related]
9. Mice with
Larrivee CL; Feng H; Quinn JA; Shaw VS; Leipprandt JR; Demireva EY; Xie H; Neubig RR
J Pharmacol Exp Ther; 2020 Apr; 373(1):24-33. PubMed ID: 31907305
[TBL] [Abstract][Full Text] [Related]
10. Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder.
Ananth AL; Robichaux-Viehoever A; Kim YM; Hanson-Kahn A; Cox R; Enns GM; Strober J; Willing M; Schlaggar BL; Wu YW; Bernstein JA
Pediatr Neurol; 2016 Jun; 59():81-4. PubMed ID: 27068059
[TBL] [Abstract][Full Text] [Related]
11. Expanding Phenotype of De Novo Mutations in GNAO1: Four New Cases and Review of Literature.
Schorling DC; Dietel T; Evers C; Hinderhofer K; Korinthenberg R; Ezzo D; Bönnemann CG; Kirschner J
Neuropediatrics; 2017 Oct; 48(5):371-377. PubMed ID: 28628939
[No Abstract] [Full Text] [Related]
12. A case of severe movement disorder with GNAO1 mutation responsive to topiramate.
Sakamoto S; Monden Y; Fukai R; Miyake N; Saito H; Miyauchi A; Matsumoto A; Nagashima M; Osaka H; Matsumoto N; Yamagata T
Brain Dev; 2017 May; 39(5):439-443. PubMed ID: 27916449
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic review on GNAO1-associated movement disorder.
Feng H; Khalil S; Neubig RR; Sidiropoulos C
Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
[TBL] [Abstract][Full Text] [Related]
14. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.
Koy A; Cirak S; Gonzalez V; Becker K; Roujeau T; Milesi C; Baleine J; Cambonie G; Boularan A; Greco F; Perrigault PF; Cances C; Dorison N; Doummar D; Roubertie A; Beroud C; Körber F; Stüve B; Waltz S; Mignot C; Nava C; Maarouf M; Coubes P; Cif L
J Neurol Sci; 2018 Aug; 391():31-39. PubMed ID: 30103967
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N
Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631
[TBL] [Abstract][Full Text] [Related]
16. GNAO1 Mutation-Induced Pediatric Dystonic Storm Rescue With Pallidal Deep Brain Stimulation.
Honey CM; Malhotra AK; Tarailo-Graovac M; van Karnebeek CDM; Horvath G; Sulistyanto A
J Child Neurol; 2018 May; 33(6):413-416. PubMed ID: 29661126
[TBL] [Abstract][Full Text] [Related]
17. GNAO1 mutation-related severe involuntary movements treated with gabapentin.
Akasaka M; Kamei A; Tanifuji S; Asami M; Ito J; Mizuma K; Oyama K; Tokutomi T; Yamamoto K; Fukushima A; Takenouchi T; Uehara T; Suzuki H; Kosaki K
Brain Dev; 2021 Apr; 43(4):576-579. PubMed ID: 33358199
[TBL] [Abstract][Full Text] [Related]
18. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
[TBL] [Abstract][Full Text] [Related]
19. GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females.
Marcé-Grau A; Dalton J; López-Pisón J; García-Jiménez MC; Monge-Galindo L; Cuenca-León E; Giraldo J; Macaya A
Orphanet J Rare Dis; 2016 Apr; 11():38. PubMed ID: 27072799
[TBL] [Abstract][Full Text] [Related]
20. Movement disorder in
Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
